Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
6.48
+0.28 (4.52%)
May 16, 2025, 4:10 PM AEST

Mayne Pharma Group Market Cap

Mayne Pharma Group has a market cap or net worth of 526.47 million as of May 16, 2025. Its market cap has decreased by -12.08% in one year.

Market Cap
526.47M
Enterprise Value
441.43M
Revenue
413.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.48

Market Cap Chart

Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 526.47M, an increase of 1,053.04%. That is a compound annual growth rate of 14.64%.

History

DateMarket Cap% Change
May 15, 2025503.72M24.75%
Dec 31, 2024403.79M-19.19%
Dec 29, 2023499.66M43.60%
Dec 30, 2022347.96M-33.16%
Dec 31, 2021520.63M-10.12%
Dec 31, 2020579.28M-20.69%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 116.12B
Pro Medicus 27.70B
Cochlear 17.60B
Sonic Healthcare 12.82B
Telix Pharmaceuticals 8.64B
Ramsay Health Care 8.29B
Ansell 4.72B
Mesoblast 2.32B
Market Cap Rankings